Document Detail

Clinical and serological heterogeneity in patients with anticentromere antibodies.
MedLine Citation:
PMID:  16078324     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To evaluate the clinical and serological heterogeneity in patients with anticentromere antibodies (ACA). METHODS: One hundred twenty patients with ACA were analyzed retrospectively. ACA were detected initially on the basis of indirect immunofluorescence on HEp-2 cells, and then antibodies to CENP-B were measured by ELISA. Antibodies to other nuclear antigens were also detected by double immunodiffusion and/or ELISA. RESULTS: Eighty-four patients (70.0%) had systemic sclerosis (SSc; scleroderma) and 36 patients (30.0%) had other rheumatic diseases or miscellaneous disorders. Among patients with SSc, 35 patients (41.7%) had SSc in overlap mostly with Sjögren's syndrome (SS), in part with rheumatoid arthritis and/or primary biliary cirrhosis (PBC). Five of 36 patients (13.9%) without SSc also had overlap syndrome of more than 2 rheumatic diseases or PBC. All CREST features (calcinosis, Raynaud's, esophageal dysmotility, sclerodactyly, telangiectasias) were found significantly more in SSc than in other diseases. A combination of RST was the most frequently seen, followed by CREST and CRST in the SSc group. In contrast, 22 of 36 patients (61.1%) without SSc had no CREST features, and the rest had only Raynaud's phenomenon and/or telangiectasia. Twenty-five of 75 patients (33.3%) with SSc and 6 of 25 patients (24.0%) with other diseases had a slight elevation of creatine phosphokinase concentration with no apparent myositis signs and/or skin lesions, suggesting a new additional sign of patients with ACA. Seventy-two patients (60.0%) had ACA alone and 48 patients (40%) had ACA mixed with other disease marker antinuclear antibodies (ANA). ACA alone occurred more frequently in patients with SSc and in the non-overlap group, whereas patients with ACA mixed with other ANA were more frequently found in the other disease and the overlap syndrome groups. Anti-CENP-B ELISA levels of the SSc group were significantly higher than those of other disease groups in all patients, in patients with ACA alone, and in patients having ACA together with other ANA. The most frequently concurrent ANA were anti-SSA/Ro antibodies; and the other ANA, including anti-SSB/La, RNP, topoisomerase-I, Jo-1, Ku, and dsDNA antibodies, were also positive alone or combined with more than 2 ANA in patients with ACA. Five patients with CREST syndrome having ACA and anti-RNP antibodies had clinical manifestations compatible with mixed connective tissue disease. SS was found in 37.0% of patients who had higher anti-CENP-B ELISA levels and higher coincidence of anti-SSA/Ro antibodies than the patients without SS. CONCLUSION: ACA were positive mostly in patients with SSc with CREST features and partly in other rheumatic disorders. The high levels of ACA may be necessary for the development of CREST features, and frequent concurrence of other disease marker ANA may contribute to the development of heterogeneous clinical characteristics, including overlap syndrome, in patients with ACA.
Shoji Miyawaki; Hiroko Asanuma; Susumu Nishiyama; Yasuhiko Yoshinaga
Related Documents :
21642854 - Cognitive-behavioral classifications of chronic pain in patients with multiple sclerosis.
17693444 - Atorvastatin therapy improves endothelial-dependent vasodilation in patients with syste...
17709664 - Chronic urticaria and monoclonal igm gammopathy (schnitzler syndrome): report of 11 cas...
3382174 - Clinical and neuropathological findings in systemic lupus erythematosus: the role of va...
9149184 - Dietary and nutritional abnormalities in alcoholic liver disease: a comparison with chr...
10599654 - Radiation-associated choroidal neovasculopathy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of rheumatology     Volume:  32     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-03     Completed Date:  2005-09-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  1488-94     Citation Subset:  IM    
Rheumatic Diseases Center, Kurashiki Medical Center, Okayama, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arthritis, Rheumatoid / epidemiology,  immunology
Autoantibodies / blood*
CREST Syndrome / epidemiology,  immunology
Centromere / immunology*
Liver Cirrhosis, Biliary / epidemiology,  immunology
Lupus Erythematosus, Systemic / epidemiology,  immunology
Middle Aged
Retrospective Studies
Rheumatic Diseases / epidemiology*,  immunology*
Scleroderma, Systemic / epidemiology,  immunology
Seroepidemiologic Studies
Sjogren's Syndrome / epidemiology,  immunology
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  HLA markers for susceptibility and expression in scleroderma.
Next Document:  Proposed core set of outcome measures in patients with primary Sjögren's syndrome: 5 year follow up...